{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:46:27Z","timestamp":1768679187120,"version":"3.49.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1365-2230.2009.03250.x","type":"journal-article","created":{"date-parts":[[2009,5,26]],"date-time":"2009-05-26T08:39:23Z","timestamp":1243327163000},"page":"603-604","source":"Crossref","is-referenced-by-count":15,"title":["Imatinib: a designer drug, another cutaneous complication"],"prefix":"10.1093","volume":"34","author":[{"given":"E.","family":"Dickens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bienz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukaemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB2","first-page":"228","article-title":"Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate","volume":"5","author":"Scheinfeld","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1067\/mjd.2003.44","article-title":"Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukaemias: a prospective study of 54 patients","volume":"48","author":"Valeyrie","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB4","first-page":"1152","article-title":"Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukaemia","volume":"46","author":"Shimizu","year":"2005","journal-title":"Rinsho Ketsueki"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1346-8138.2007.00369.x","article-title":"Exacerbation of psoriasis in a chronic myelogenous leukaemia patient treated with imatinib","volume":"34","author":"Woo","year":"2007","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2133.2002.497217.x","article-title":"Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour","volume":"147","author":"Miyagawa","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1365-2133.2006.07262.x","article-title":"Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia","volume":"154","author":"Deguchi","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1523-1747.ep12476485","article-title":"Increased dermal expression of platelet-derived growth factor receptors in growth activated skin wounds and psoriasis","volume":"96","author":"Krane","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0923-1811(00)00095-5","article-title":"Possible contribution of stem cell factor in psoriasis vulgaris","volume":"24","author":"Yamamoto","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2230.2009.03250.x-BIB10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.exphem.2007.04.016","article-title":"Modulation of T-effector function by imatinib at the level of cytokine secretion","volume":"35","author":"Leder","year":"2007","journal-title":"Exp Hematol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03250.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03250.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:28:49Z","timestamp":1676384929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/5\/603\/6625021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03250.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}